MedPath

Nemonoxacin

Generic Name
Nemonoxacin
Drug Type
Small Molecule
Chemical Formula
C20H25N3O4
CAS Number
378746-64-6
Unique Ingredient Identifier
P94L0PVO94

Overview

No overview information available.

Indication

Investigated for use/treatment in bacterial infection and pneumonia.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/11/24
Phase 4
Completed
2018/06/11
Phase 3
Completed
R-Pharm
2017/12/05
Phase 1
Completed
2016/07/21
Phase 1
UNKNOWN
2015/11/13
Phase 1
Completed
2014/07/31
Phase 3
Completed
2013/09/18
Phase 2
Completed
2012/02/23
Phase 2
Completed
2012/02/09
Phase 1
Completed
2012/02/08
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Nemonoxacin Malate Capsules
国药准字H20160006
化学药品
胶囊剂
3/9/2021
Nemonoxacin Malate and Sodium Chloride Injection
国药准字H20210024
化学药品
注射剂
6/18/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath